Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,805 | 18,204 | 5,997 | 11 | 10 |
| Marketable Securities | 191,799 | 9,556 | 133 | 0 | N/A |
| Receivables | 12,458 | 7,960 | N/A | N/A | N/A |
| Inventories | 2,536 | 801 | N/A | N/A | N/A |
| Other current assets | 46,849 | 0 | 0 | 0 | 7 |
| TOTAL | $301,932 | $37,334 | $7,501 | $33 | $17 |
| Non-Current Assets | |||||
| PPE Net | 428 | 671 | 127 | 24 | 3 |
| Investments And Advances | 0 | 0 | 244 | 0 | 0 |
| Intangibles | 162,472 | 95,201 | 12,586 | 2,197 | 0 |
| Other Non-Current Assets | 47,432 | 2,265 | 40 | 138 | 0 |
| TOTAL | $210,332 | $98,137 | $12,998 | $2,358 | $3 |
| Total Assets | $512,264 | $135,471 | $20,499 | $2,391 | $20 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,639 | 7,124 | 3,554 | 1,047 | 386 |
| Accrued Expenses | 23,820 | 27,883 | 4,881 | 2,468 | 170 |
| Other current liabilities | 55,522 | 32,046 | 28,130 | 1,400 | N/A |
| TOTAL | $86,981 | $107,539 | $36,565 | $5,799 | $556 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 100,984 | 65,042 | 1,000 | 0 | 0 |
| TOTAL | $125,312 | $65,183 | $3,601 | $N/A | $N/A |
| Total Liabilities | $212,293 | $172,722 | $40,166 | $5,799 | $556 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,509 | 26,487 | 35,073 | 12,071 | N/A |
| Common Shares | 4 | 3 | 2 | 1 | 0 |
| Retained earnings | -65,153 | -179,175 | -68,237 | -33,612 | -3,268 |
| Other shareholders' equity | -682 | 4,070 | -67 | 0 | -35 |
| TOTAL | $299,971 | $-37,251 | $-19,667 | $-3,408 | $-536 |
| Total Liabilities And Equity | $512,264 | $135,471 | $20,499 | $2,391 | $20 |